Related Experiment Video
Updated: Jun 9, 2026

A Tripeptide-Stabilized Nanoemulsion of Oleic Acid
Published on: February 27, 2019
Design Principles, Synthetic Strategies, and Biomedical Applications of Peptide-Polymer Conjugates.
Zhuo-Ran Yang1, Zhonghao Li1, Xingjun Zhao2
1Hubei Engineering Research Center for Biomaterials and Medical Protective Materials, School of Chemistry and Chemical Engineering, Huazhong University of Science and Technology (HUST), Wuhan 430074, China.
Peptide-polymer conjugates enhance peptide drug stability and efficacy. This review covers their design, synthesis, applications in drug delivery and tissue engineering, and future directions for clinical translation.
Area of Science:
- Biomaterials Science
- Drug Delivery Systems
- Pharmaceutical Chemistry
Background:
- Peptides offer high selectivity and biocompatibility for drug development.
- Poor in vivo stability and short half-life limit peptide therapeutic applications.
- Peptide-polymer conjugates improve pharmacokinetic properties and therapeutic efficacy.
Purpose of the Study:
- To systematically review the design principles and synthetic strategies of peptide-polymer conjugates.
- To elaborate on the applications of these conjugates in drug delivery, immunotherapy, and tissue engineering.
- To discuss current challenges and future prospects for peptide-based therapeutics.
Main Methods:
- Review of covalent bonding, physical association, and self-assembly conjugation mechanisms.
- Analysis of applications in drug delivery, immunotherapy, and tissue engineering.
- Discussion of challenges like conjugation site control and immunogenicity.
Main Results:
- Peptide-polymer conjugation significantly enhances in vivo stability and therapeutic efficacy.
- Diverse synthetic strategies enable tailored conjugate properties.
- Applications span drug delivery, immunotherapy, and tissue engineering.
Conclusions:
- Peptide-polymer conjugates are a promising strategy to overcome limitations of peptide therapeutics.
- Controlling conjugation sites and managing immunogenicity are key challenges.
- Development of responsive intelligent systems is envisioned for clinical translation.
Related Concept Videos
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Modified-Release Drug Delivery Systems: Site-Targeted

